In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
The Florida Treasure Coast started the new year with a surge of 1,905 new home listings—up 22 percent from last January—signaling one of the strongest inventory jumps in years. While Martin County saw its median home price drop by nearly $100,000, nearby St. Lucie and Indian River counties continued to rise, creating a uniquely mixed market. With sales climbing and inventory levels shifting toward a more buyer-friendly landscape, 2026 is shaping up to be an active and opportunity-rich year for both seasoned agents and those entering the real estate field.
A unanimously passed House bill, HB 767, aims to require insurers to publicly disclose rate and premium data—giving Floridians long‑awaited clarity on rising costs. If approved by the Senate, the measure could significantly impact homeowners, real estate agents, mortgage professionals, and insurance specialists by increasing consumer trust and revealing how insurers calculate premiums.
U.S. mortgage rates have dipped to 5.98 percent, breaking below the 6 percent mark for the first time since 2022 and giving the spring home-buying season a fresh boost. With rates falling for the third straight week and buyer interest rising, experts say this shift could encourage more market activity—though many homeowners with ultra‑low pandemic-era rates may still hesitate to sell.
Artificial intelligence is rapidly transforming real estate, from listing creation to MLS infrastructure, forcing the industry to rethink how data is used, altered and protected. With AI tools making it easier than ever to modify photos, automate marketing and process sensitive documents, MLSs and state regulators are racing to establish new guardrails that ensure accuracy, privacy and consumer protection without slowing innovation.
Today’s real estate pros juggle nonstop client demands, constant marketing, and mountains of paperwork—but AI is stepping in as the ultimate assistant. From instant lead responses and personalized follow-up messages to predictive pricing tools and automated transaction support, agents are using AI to save hours, boost production, and stay competitive. The future of real estate belongs to professionals who combine their human touch with smart technology, and the shift is already happening.
A landmark US Supreme Court decision striking down the use of emergency powers to impose broad tariffs has upended global trade expectations, lifted equity markets, and sent businesses scrambling to understand what comes next. While GDP slowed and inflation rose, markets reacted positively as the ruling removed a major source of uncertainty for importers, exporters, and investors. With the old tariff framework dismantled and new targeted measures on the horizon, industries from real estate to finance are bracing for shifting economic conditions that could influence everything from consumer spending to investment strategy.
